Haibo Ding
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Virology 49
- HIV Research and Treatment 49
-
- HIV/AIDS Research and Interventions 26
- HIV/AIDS drug development and treatment 18
- Co-authors
- Hong Shang (61 shared papers)Junjie Xu (42 shared papers)Zining Zhang (38 shared papers)Xiaoxu Han (47 shared papers)Zhenxing Chu (29 shared papers)Yongjun Jiang (38 shared papers)Qinghai Hu (20 shared papers)Yajing Fu (25 shared papers)
- Journals
- Frontiers in Immunology (12 papers)BMC Infectious Diseases (9 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (4 papers)Journal of Translational Medicine (4 papers)mBio (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Haibo Ding
111 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 110
- Virology 408
- Infectious Diseases 471
- Immunology 303
- Emergency Medicine 87
- Epidemiology 304
Countries citing papers authored by Haibo Ding
This map shows the geographic impact of Haibo Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haibo Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haibo Ding more than expected).
Fields of papers citing papers by Haibo Ding
This network shows the impact of papers produced by Haibo Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haibo Ding. The network helps show where Haibo Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Haibo Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 108 | |
| 2 | 2018 | 51 | |
| 3 | 2016 | 50 | |
| 4 | 2020 | 47 | |
| 5 | 2018 | 46 | |
| 6 | 2017 | 45 | |
| 7 | 2011 | 43 | |
| 8 | 2017 | 34 | |
| 9 | 2010 | 32 | |
| 10 | 2021 | 31 | |
| 11 | 2021 | 31 | |
| 12 | 2019 | 30 | |
| 13 | 2017 | 29 | |
| 14 | 2015 | 27 | |
| 15 | 2019 | 25 | |
| 16 | 2018 | 25 | |
| 17 | 2014 | 25 | |
| 18 | 2019 | 24 | |
| 19 | 2017 | 23 | |
| 20 | 2016 | 23 |
About Haibo Ding
Haibo Ding is a scholar working on Virology, Infectious Diseases, Immunology, Emergency Medicine and Epidemiology, having authored 121 papers that have together received 1.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (49 papers), Immune Cell Function and Interaction (29 papers), HIV/AIDS Research and Interventions (26 papers), HIV/AIDS drug development and treatment (18 papers), HIV-related health complications and treatments (16 papers), T-cell and B-cell Immunology (7 papers), Reproductive System and Pregnancy (5 papers) and HIV, Drug Use, Sexual Risk (5 papers). The work is most often cited by research in Virology (408 citations), Infectious Diseases (471 citations), Immunology (303 citations), Emergency Medicine (87 citations) and Epidemiology (304 citations). Haibo Ding has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hong Shang, Junjie Xu, Zining Zhang, Xiaoxu Han, Zhenxing Chu, Yongjun Jiang, Qinghai Hu, Yajing Fu, Bin Zhao and Wenqing Geng. Their work appears in journals such as Frontiers in Immunology, BMC Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Translational Medicine and mBio.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.